Volixibat

• Description:

  A highly potent and selective inhibitor of the apical sodium-dependent bile acid transporter (ASBT) in development for the treatment of nonalcoholic steatohepatitis (NASH) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  805.96

• Molecular Formula:

  C38H51N3O12S2

• Notes:

  Research use only, not for human use.

• Receptor:

  ASBT Transporter

• CAS Number:

  1025216-57-2